IntroductIon
Left ventricular thrombus (LVT) is a well-recognized complication of acute myocardial infarction (AMI). The incidence of LVT for patients treated conservatively has been reported to be 20-57%. In myocardial infarction survivors the incidence of LVT depends on location, magnitude, time of hospital admission, thrombolytic therapy, ejection fraction. It occurs mostly in those with large anterior Q-wave infarctions, particularly in the presence of a left ventricular aneurysm (1, 2, 3) .
The incidence of LVT after primary percutaneous coronary intervention (PPCI) for AMI has been reported to be from 4% to 12%. The most important parameter confirmed to be time of revascularization (4, 5). The clinical significance of LV thrombi lies on their potential risk of systemic embolization. The incidence of stroke in the acute phase following MI is approximately 5.4% and up to 91% reported in patients with documented left ventrıcular thrombus (6, 7) .
The long-term risk of stroke following MI is about 6%. Strokes are mainly ischemic. Risk factors include advancing age, diabetes mellitus, previous history of stroke, history of hypertension, and smoking (8) .
Left ventricular thrombus complicating (AMI) results from turbulent blood flow and stasis related to an akinetic left ventricular wall segment or aneurysm. Predictors of left ventricular thrombus were low ejection fraction and severe mitral regurgitation. Possible causes of LVT include segmental dysfunction of the infarcted myocardium causing stasis, endocardial tissue inflammation providing a thrombogenic surface. There is evidence that LVT usually develop within a few days after AMI (9, 10) .
Catheter-based reperfusion therapy is superior to thrombolysis in promoting early myocardial recovery, with improved clinical outcomes (11) . A recent meta-analysis suggests that angioplasty provides a short-term clinical advantage over thrombolysis (12) .
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compared to conservative treatment diographic assessment of LV mural thrombus (13).
Methods
This study was approved by the Committee of Ethics. Written informed consent was obtained from the patients prior to enrolment. This is prospective study performed in two different cardiologic centers, with different possibilities to treat acute myocardial infarction; one conservatively and another invasively. Four hundred consecutive patients with ST elevation acute myocardial infarction (STEMI) were enrolled in the study. Baseline demographic characteristics, type of treatment, and other therapies instituted were recorded. Two-dimensional echocardiography was performed using a Vivid-S5 ultrasound machine (GE Medical Systems) and iE33 Philips ultrasound. within two days of infarction. Two level echocardiographers blinded to the clinical details separately reviewed the echo images in each patient. LV thrombus was defined as an echodense mass with definite margins, contiguous but distinct from the endocardium, adjacent to an area of hypo-or akinetic myocardium.
Two-hundred patients were treated with conservative treatment, non-PCI group and 200 with primary percutaneous coronary intervention, PCI group. PCI was successful in all patients. The time delay from symptom onset to intervention was 180 minutes. Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow was achieved in 95% of cases. Structural index, mean average, standard deviation, t-test and Chi2 were derived by SigmaStat and SPSS program.
resuLts
Four-hundred patients were enrolled in the study. First group, 200 patients treated with PCI in early hours of AMI (within 3 hours), second group (200 patients) received conservative treatment either with or without thrombolytic. Mean age of the first group was 58.95 years and 57.58 years for the second group.
There were no significant baseline demographic data differences. Significant differences between groups can be seen with treatment with Low Molecular Weight Heparin (LMWH) and streptokinase (STK) (due to current protocols for treatment of AMI (Table 1) .
Stents were deployed in all (200) patients of PCI-group. TIMI III flow in the infarct related vessel was achieved in 190 patients, whereas TIMI II was achieved in 10 patients. Four patient in PCI group had LV thrombus, 2% of the total (4/200) (Table 2) or 5.6% (4/71) of them with anterior MI (Table 3) .
In non-PCI group 50 patients had LVT, 25% of the total (50/200) ( Table  2 ). In the anterior subgroup thrombus was present in 94% (47/50) of cases (Table 4) . Only in 6% (3/50) of cases the thrombus was detected in inferior MI (Table 4) .
Comparison of incidence of LVT of two different treatment (PCI vs. non-PCI) resulted to be with high significant difference (p≤0.0003) ( Table 2 ). In PCI group LVT were located always in anterior MI, 5.6 % (4/71) of cases. No patient of PCI group with an inferior/lateral MI had LV thrombus.
In non-PCI group anterior MI was present in 53% (106/200) of cases, with thrombus being present in 44.4% 47/106). Whereas, 39.5% (79/200) of patients from the non-PCI group had inferior MI, with only 3.5% (3/79) being diagnosed with LVT.
Stroke (hemorrhagic) was present in one case in PCI group and no ischemic stroke was present in this group.
In Non-PCI group presence of ischemic stroke was significant 16% in patients with LVT and in 4% of total.
dIscussIon
Left ventricular mural thrombus is widely accepted as complication of acute myocardial infarction, with extreme range of reported possibilities for stroke (9) . Strategies to prevent LVT as complication, present an important therapeutic goal since patients with LV thrombi have a worse overall prognosis (5).
Keeley et al. in the era of non-PCI treatment of AMI reported the incidence of LVT complicating AMI to be 20-57%.D1 We found this incidence to be 25% in non-PCI group and in more than 44% in anterior AMI. The incidence of LVT was only 3.5% in inferior AMI. Almost always when thrombi were present (94%), they were located in the apex of the left ventricle. Our results have shown high incidence of LVT in non-PCI group and very low incidence in PCI group. Mansencal N et al. reported the incidence of LV thrombus in patients treated with primary PCI for AMI to be 12% and this incidence was related to time of revascularization (5). Kalra et al. also has found this correlation between LVT and time of revascularization, but with lower maximum incidence of 4%, which was similar with our data of 2%. There were no differences between two treatment groups (PCI vs. non-PCI) in relation to basic demographic data.
Differences exist, as depicted in Table 1, in medical treatment according to current protocols. We found out that PCI is superior to non-PCI in the incidence of LVT (2% vs. 25% p≤0.0003). The incidence of strokes in the acute phase following MI is approximately 5.4% and up to 91% reported in patients with documented left ventrıcular thrombus (7) .
Sixteen percent of patients with LVT in non-PCI group had strokes, and just 0.66% in patients of non-PCI group without LVT. No patients of PCI group had ischemic stroke and one had hemorrhagic stroke.
concLusIon
PCI treatment is highly effective in reducing LVT and strokes compared to non-PCI treatment. Further studies are needed to elucidate treatment protocols for non-PCI treatment of anterior AMI, in order to reduce the LVT incidence when PCI is not possible to be performed.
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